Cognitive and behavioral effects of cannabidiol in patients with treatment-resistant epilepsy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cognitive and behavioral effects of cannabidiol in patients with treatment-resistant epilepsy
Authors
Keywords
Cannabidiol, Epilepsy, Treatment-resistant, Cognitive, Behavioral, Adverse effects
Journal
EPILEPSY & BEHAVIOR
Volume 114, Issue -, Pages 107558
Publisher
Elsevier BV
Online
2020-11-25
DOI
10.1016/j.yebeh.2020.107558
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety
- (2020) Simona Lattanzi et al. CNS DRUGS
- Cannabidiol in treatment of refractory epileptic spasms: An open-label study
- (2020) Aline Herlopian et al. EPILEPSY & BEHAVIOR
- fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy
- (2019) Jane B. Allendorfer et al. EPILEPSY & BEHAVIOR
- Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy
- (2019) Roy C. Martin et al. EPILEPSY & BEHAVIOR
- Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use
- (2019) Paulo Fleury-Teixeira et al. Frontiers in Neurology
- Cannabidiol for treatment of refractory childhood epilepsies: Experience from a single tertiary epilepsy center in Slovenia
- (2018) David Neubauer et al. EPILEPSY & BEHAVIOR
- Open-label use of Highly* purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
- (2018) Orrin Devinsky et al. EPILEPSY & BEHAVIOR
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
- (2018) Ila M. P. Linares et al. Frontiers in Pharmacology
- Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System
- (2018) Patrícia Schonhofen et al. CNS DRUGS
- Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice
- (2018) David Cheng et al. JOURNAL OF ALZHEIMERS DISEASE
- Cannabidiol for Treatment of Childhood Epilepsy–A Cross-Sectional Survey
- (2018) Kerstin A. Klotz et al. Frontiers in Neurology
- Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
- (2018) Kerri A. Schoedel et al. EPILEPSY & BEHAVIOR
- Pharmacology of cannabinoids in the treatment of epilepsy
- (2017) Tyler E. Gaston et al. EPILEPSY & BEHAVIOR
- Cannabinoids in treatment-resistant epilepsy: A review
- (2017) Brooke K. O'Connell et al. EPILEPSY & BEHAVIOR
- Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
- (2017) Douglas L Boggs et al. NEUROPSYCHOPHARMACOLOGY
- A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
- (2017) Ashleigh L. Osborne et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis
- (2017) Britta Hahn SCHIZOPHRENIA BULLETIN
- CBD-enriched medical cannabis for intractable pediatric epilepsy
- (2016) Michal Tzadok et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
- (2015) Chandni Hindocha et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans
- (2015) Alex F. Manini et al. Journal of Addiction Medicine
- Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa
- (2015) Mohamed M. Radwan et al. JOURNAL OF NATURAL PRODUCTS
- Cannabinoids in the Treatment of Epilepsy
- (2015) Daniel Friedman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ9tetrahydrocannabinol
- (2013) M Jerry Wright et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started